The Current Ratio of Compass Pathways PLC (CMPS) is
0.77.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
0.77
|
| 2024-12-31 |
5.92
|
| 2023-12-31 |
13.33
|
| 2022-12-31 |
12.29
|
| 2021-12-31 |
19.56
|
| 2020-12-31 |
29.33
|
| 2019-12-31 |
1.35
|
| 2018-12-31 |
14.61
|
| Ticker |
Name |
Value |
|
KNTE
|
Kinnate Biopharma Inc
|
13.19
|
|
OXB.L
|
Oxford Biomedica PLC
|
2.20
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
4.16
|
|
ANNX
|
Annexon, Inc.
|
5.68
|
|
IMCR
|
Immunocore Holdings PLC
|
4.04
|
|
OCGN
|
Ocugen, Inc.
|
1.06
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
4.41
|
|
CYDY
|
Cytodyn Inc
|
0.26
|
|
GNS.L
|
Genus PLC
|
2.21
|
|
PCVX
|
Vaxcyte, Inc.
|
7.91
|
|
NKTX
|
Nkarta, Inc.
|
12.69
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
0.06
|
|
VBIV
|
VBI Vaccines Inc
|
0.48
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.82
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
9.39
|
|
KRYS
|
Krystal Biotech, Inc.
|
9.95
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
10.22
|
|
STTK
|
Shattuck Labs Inc
|
11.70
|
|
ABC.L
|
Abcam PLC
|
1.13
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
2.92
|
|
SLN.L
|
Silence Therapeutics PLC
|
2.99
|
|
TRIL.TO
|
Trillium Therapeutics Inc
|
13.95
|
|
FPRX
|
Five Prime Therapeutics Inc
|
13.18
|
|
ITOS
|
iTeos Therapeutics Inc
|
12.75
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7.81
|
|
CNTA
|
Centessa Pharmaceuticals Limited
|
8.57
|
|
KNSA
|
Kiniksa Pharmaceuticals International, PLC
|
3.79
|
|
MYOV
|
Myovant Sciences Ltd
|
1.95
|
|
QURE
|
uniQure N.V.
|
10.43
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
3.17
|
|
BCYC
|
Bicycle Therapeutics PLC
|
11.98
|
|
STOK
|
Stoke Therapeutics, Inc.
|
5.28
|
|
ZYME
|
Zymeworks Inc.
|
5.88
|
|
KROS
|
Keros Therapeutics, Inc.
|
15.45
|
|
REPL
|
Replimune Group, Inc.
|
4.79
|
|
IMVT
|
Immunovant, Inc.
|
9.09
|
|
KRON
|
Kronos Bio LLC
|
7.54
|